Weeks 13-16: Retatrutide 4 mg weekly (hold steady) + Cagrilintide 0.5 mg weekly
An understanding of the appropriate format and dose for the desired effect 5
Experience personalized care today
Seizures preferentially stimulate proliferation of radial glia-like astrocytes in the adult dentate gyrus: functional and immunocytochemical analysis
More serious side effects that require urgent or emergency medical help may include allergic reactions, acute kidney injury, and inflammation of the gallbladder
One should not use AOD-9604 if they: Are pregnant or breastfeeding Are a minor Have a current or recent history of cancer (particularly hormone-sensitive cancers) Have uncontrolled diabetes or significant insulin resistance Have active thyroid disease that is not well-managed Are taking medications that may interact with peptide therapy (discuss with your provider) Have a known hypersensitivity to peptide compounds Comprehensive labs including metabolic panel, fasting glucose, HbA1c, thyroid panel, lipid panel, and hormone levels should be run before starting any peptide therapy and monitored regularly throughout